PIA
ANGO icon

Piedmont Investment Advisors’s AngioDynamics ANGO Stock Holding History

Piedmont Investment Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,318
Closed -$213K – 957
2019
Q1 		$213K Buy
+9,318
New +$202K 0.01% 1039
2018
Q3 		– Sell
-8,570
Closed -$191K – 1101
2018
Q2 		$191K Buy
+8,570
New +$175K 0.01% 860

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Piedmont Investment Advisors's ANGO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 9,318 shares — an estimated $213K sold.

Piedmont Investment Advisors first reported a position in ANGO in Q2 2018 and held it in 2 quarters. The position peaked at $213K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 9,318 AngioDynamics shares in Q2 2019, an estimated $213K.
  • Piedmont Investment Advisors first reported a position in AngioDynamics in Q2 2018 and held it in 2 quarters.
  • Piedmont Investment Advisors's AngioDynamics position peaked at $213K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.